| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
China Reform Health Management and Services Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥8.36 |
| 52 Week High | CN¥15.83 |
| 52 Week Low | CN¥7.67 |
| Beta | 0.77 |
| 1 Month Change | -18.60% |
| 3 Month Change | -24.75% |
| 1 Year Change | -19.54% |
| 3 Year Change | -0.59% |
| 5 Year Change | -62.36% |
| Change since IPO | 1,160.68% |
Recent News & Updates
Shareholder Returns
| 503 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 0.1% | 1.9% | 1.6% |
| 1Y | -19.5% | -32.4% | -15.1% |
Return vs Industry: 000503 exceeded the CN Healthcare industry which returned -32.4% over the past year.
Return vs Market: 000503 underperformed the CN Market which returned -15.1% over the past year.
Price Volatility
| 503 volatility | |
|---|---|
| 503 Average Weekly Movement | 8.4% |
| Healthcare Industry Average Movement | 6.8% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.3% |
Stable Share Price: 000503's share price has been volatile over the past 3 months.
Volatility Over Time: 000503's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 1,621 | Yonghua Li | www.crhms.cn |
China Reform Health Management and Services Group Co., Ltd. offers medical insurance management services in China. The company is involved in business that covers 177 medical insurance in 25 provinces.
China Reform Health Management and Services Group Co., Ltd. Fundamentals Summary
| 503 fundamental statistics | |
|---|---|
| Market cap | CN¥8.12b |
| Earnings (TTM) | -CN¥76.50m |
| Revenue (TTM) | CN¥337.45m |
24.4x
P/S Ratio-107.5x
P/E RatioIs 503 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 503 income statement (TTM) | |
|---|---|
| Revenue | CN¥337.45m |
| Cost of Revenue | CN¥249.02m |
| Gross Profit | CN¥88.42m |
| Other Expenses | CN¥164.93m |
| Earnings | -CN¥76.50m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 27, 2024
| Earnings per share (EPS) | -0.078 |
| Gross Margin | 26.20% |
| Net Profit Margin | -22.67% |
| Debt/Equity Ratio | 29.7% |
How did 503 perform over the long term?
See historical performance and comparison